As of Nov 11
| +0.46 / +0.21%|
The 5 analysts offering 12-month price forecasts for Abiomed Inc have a median target of 240.00, with a high estimate of 255.00 and a low estimate of 215.00. The median estimate represents a +9.05% increase from the last price of 220.08.
The current consensus among 9 polled investment analysts is to Buy stock in Abiomed Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.